Mechanism of Action
Glycine acts at several levels. On the antioxidant side, it supplies one of the three amino acids needed to assemble glutathione. This tripeptide, made of glutamate, cysteine and glycine, is built in two enzymatic steps within the cytoplasm of every cell.
Structurally, glycine slots into the collagen triple helix on a repeating pattern, one glycine for every two other amino acids. Its small size lets it occupy the centre of that helix, where no other amino acid fits. This positioning governs the stability and mechanical strength of connective tissue.
Neurologically, glycine binds to specific receptors in the brainstem and spinal cord, where it dampens nerve transmission. The pathway proposed to explain its effect on sleep comes from the laboratory: in rats, oral glycine increases blood flow to the skin and lowers core body temperature, two signals that normally accompany sleep onset.
Key Benefits
- Emerging
Faster sleep onset and sleep rated as more satisfying: in adults who reported poor sleep quality, 3 g of glycine taken 30 to 60 minutes before bedtime, over two to four days, shortened sleep onset latency measured by polysomnography and improved reported satisfaction.
- Emerging
Less fatigue the day after a short night: in seven volunteers whose sleep time was cut by a quarter for three nights, 3 g of glycine at bedtime reduced reported fatigue on the first day and improved psychomotor vigilance performance on both measured days.
Dosage & Forms
Glycine comes in two supplemental forms. Free-form L-glycine is the pure amino acid. Chelated forms, such as magnesium or zinc bisglycinate, bind two glycine molecules to a metal atom and therefore deliver glycine alongside the mineral. No human pharmacokinetic comparison sets these two forms against each other as a source of glycine.
The human trials on sleep all used 3 g, taken 30 to 60 minutes before bedtime: that is the only dose tested on this endpoint, and no dose-response relationship has been established beyond it.
Work on other markers goes considerably higher. A urological trial used 6 g per day over four weeks. Two metabolic trials used 15 g per day over three months, in people with type 2 diabetes or metabolic syndrome. A four-month trial used 14 g per day in malnourished people on dialysis.
In the Singular Formula
Inclusion rationale
The simplest and smallest amino acid, and far from the least important: glycine accounts for roughly one third of the amino acids in collagen, the most abundant protein in the human body. It is described as conditionally essential, meaning the body produces it without always keeping pace with what it consumes.
Glycine sits at a metabolic crossroads within the formula. It is a direct precursor of glutathione, alongside N-Acetylcysteine which supplies the cysteine. It is also one of the three precursors of creatine, itself present. And it provides one of the structural amino acids of type I, III and II collagens, all present.
Beyond these intersections, glycine takes part in the hepatic conjugation of bile acids and acts as an inhibitory neurotransmitter in the central nervous system. Its own human evidence lies elsewhere: in crossover trials at 3 g taken before bedtime, in adults who reported poor sleep quality.
Selected form
Glycine is the smallest and simplest of the amino acids. It accounts for roughly one third of the amino acids in collagen and provides one of the three building blocks of glutathione, the antioxidant that cells manufacture themselves. Depending on your profile, it may be present in your formula in two forms, both counted in the displayed dose.
Added as a dedicated bioactive, it comes as free-form L-glycine: the amino acid on its own, not bound to another compound. The material selected is European Pharmacopoeia grade, with an assay between 98.5 and 101.5%.
Delivered through magnesium, it comes as magnesium bisglycinate, a salt in which two glycine molecules are bound to a magnesium atom.
Formula dosage
0 to 3 g.
Dose expressed as active substance, excluding excipients and carriers of the raw material.
Synergies in the formula
Safety & Precautions
Glycine is an amino acid the body makes and consumes every day. Its tolerability profile is among the most favourable of the amino acids used in supplementation. An open study in twelve volunteers found no adverse effects after 9 g taken in a single dose, and the literature reports no serious adverse effects up to 31 g per day.
Digestive discomfort, nausea, loose stools and abdominal pain, appears at the high doses used in psychiatry, from 30 to 60 g per day. A trial at 14 g per day over four months in malnourished people on dialysis reported nausea or vomiting in six participants, with no serious event related to the supplementation.
Glycine is not advised alongside clozapine: two controlled trials found no benefit from adding it, and one suggests it could blunt the medication's efficacy. People on long-term medication are invited to consult a healthcare professional before any supplementation.
As a precaution, and in the absence of specific data, glycine supplementation is not advised during pregnancy or breastfeeding.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Soh J et al. | 2024 | Review | GeroScience | View on PubMed |
The effect of glycine administration on the characteristics of physiological systems in human adults: A systematic review Systematic review of 52 human studies across eleven physiological systems. Positive effects concentrate on the nervous system. The authors note that the sleep studies in healthy populations rest on small sample sizes with a high risk of bias. | ||||
| Bannai M, Kawai N | 2012 | Review | Journal of Pharmacological Sciences | View on PubMed |
New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep Minireview gathering three volunteer studies at 3 g before bedtime, including a double-blind crossover trial in 19 women and a crossover trial with polysomnography in 11 volunteers. The drop in core temperature and the cutaneous vasodilation reported there were measured in rats, at 2 g/kg, not in humans. | ||||
| Bannai M et al. | 2012 | Randomised Controlled Trial | Frontiers in Neurology | View on PubMed |
The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers Randomized single-blind crossover trial, seven volunteers analysed, 3 g at bedtime across three nights of sleep cut by a quarter. Reported fatigue fell on day one and psychomotor vigilance improved on both measured days. Sleepiness did not change significantly. | ||||
| Kumar P et al. | 2023 | Randomised Controlled Trial | The Journals of Gerontology: Series A | View on PubMed |
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial Randomized double-blind trial, 12 older adults on GlyNAC versus 12 on placebo, 16 weeks. Doses were 100 mg per kilogram per day of each amino acid, roughly 7 g of glycine and 7 g of N-acetylcysteine. The trial includes no glycine-only arm, so the effect cannot be attributed to either component. | ||||
| Tan HC et al. | 2025 | Clinical Trial | Scientific Reports | View on PubMed |
Metabolic impact of dietary glycine supplementation in individuals with severe obesity Single-arm trial in 19 adults with severe obesity, glycine alone at 100 mg per kilogram per day for two weeks. Triglycerides and aminotransferases fell. Red blood cell total glutathione, by contrast, did not change significantly. | ||||